Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The patients comfort level, age, sex, physique, and health goals may also determine the injection location
Capsules are plant based
GHK-Cu research is currently experiencing an expansion from classical areas of application (skin, wound healing) toward systemic and neurodegenerative questions
Our human trials were approved by the Institutional Review Board for Human Subjects at Cornell University and carried out in accordance with their guidelines and regulations
Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
Copper Peptide Research for controlled studies involving copper-binding peptide complexes and related molecular behaviour
